Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 3934 of 5804
-
New surgical trick may make gallbladder removal safer
Symptom relief CompletedOur aim is to feature additional steps for safe cholecystectomy by preserving the cystic artery.
Phase: NA • Sponsor: Suez University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New HIV drug cocktail tested in newborns to block transmission
Disease control OngoingThe goal of this clinical study is to learn more about the study drug, Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), safety, tolerability, and pharmacokinetics (how B/F/TAF is absorbed, modified, distributed, and removed from the body of the participants) in neonates…
Phase: PHASE1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Blood donors watch docudrama – will it bring them back?
Knowledge-focused Recruiting nowA cluster pilot RCT to evaluate the effectiveness of the docudrama compared to a control group (usual engagement with blood services) on repeat blood donation attempts among first-time blood donors. Secondary outcomes will be blood donor retention, attitudes, subjective norms, pe…
Phase: NA • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Gratitude journaling tested as a pain relief tool for jaw disorders
Symptom relief Recruiting nowThe goal of this clinical trial is to learn whether a 2-week gratitude journaling activity is feasible and acceptable for individuals with Temporomandibular Disorder (TMD) and chronic overlapping pain. The study will also look at whether this activity is helpful in reducing pain …
Phase: NA • Sponsor: University of Florida • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Can AI help create a lasting legacy for the seriously ill?
Symptom relief Recruiting nowThe purpose of this study is to determine if it is feasible and acceptable to recruit for and deliver the AI Assisted Personalized Legacy Program intervention to patients with serious illness.
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Remote HIIT program aims to boost fitness in ANOCA patients
Knowledge-focused Recruiting nowThe main goal is to understand what causes reduced fitness in ANOCA and whether targeted exercise can help improve it. This study aims to better understand why patients with Angina and No Obstructive Coronary Artery Disease (ANOCA) have poor cardiorespiratory fitness and its eff…
Phase: NA • Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:59 UTC
-
New disposable scope aims to improve bile duct stone removal and diagnosis
Diagnosis Recruiting nowThis study plans to enroll up to 75 research subject who have a biliary disorder such as bile duct stones or intermediate biliary strictures. The purpose of this research is to assess whether the Dragonfly™ Pancreaticobiliary Scope functioned as intended in combination with the c…
Phase: PHASE4 • Sponsor: University of Colorado, Denver • Aim: Diagnosis
Last updated Jun 26, 2026 14:05 UTC
-
Wrist pain relief: new study tests blood flow trick
Symptom relief ENROLLING_BY_INVITATIONThe purpose of this study is to determine the strength, pain and functional benefits of early, low-load resistance training with blood flow restriction (BFR) in ulnar-sided wrist pain treated nonoperatively with immobilization for 4-6 weeks. Hypothesis: patients in the BFR group …
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
New Exosome-Based COVID booster enters human testing
⭐️ VACCINE ⭐️ CompletedThis phase 1 clinical trial will evaluate the safety, reactogenicity, and immunogenicity of STX-S in adults who have previously received a primary series and at least one booster with an authorized or licensed SARS-CoV-2 parenteral vaccine. The study is designed as a non-randomiz…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 28, 2026 00:00 UTC
-
New HIV drug candidate GS-1219 tested in tiny early trial
Disease control TerminatedThis study is part of a master study. The goal of master protocol (GSUS-544-5905, NCT05585307) is to learn how novel antiretrovirals (medicines that stop the virus from multiplying) affect the human immunodeficiency virus-1 (HIV-1) infection in people living with HIV (PWH). Subs…
Phase: PHASE1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New registry aims to unlock pneumonia mysteries in vulnerable patients
Knowledge-focused Recruiting nowThis multicentric, prospective study aims at: evaluating the prevalence, etiology, characteristics, and 1one-year outcomes of immunocompromised patients hospitalized for Community-Acquired Pneumonia (CAP); conducting biochemical, microbiological and genetic analysis on collected…
Sponsor: Societa Italiana di Pneumologia • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Cooking classes aim to boost nutrition for texans in opioid recovery
Knowledge-focused Recruiting nowThe purpose of the study is to assess a culinary curriculum in persons with substance use disorder who are receiving medication assisted therapy and who are in recovery residences in Texas. The curriculum has the goal of increasing nutritional knowledge and confidence in cooking …
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
AI scribes in GP clinics: do patients like them?
Knowledge-focused CompletedThis randomised control trial study explores patient satisfaction with the use of an artificial intelligence (AI) notetaker in doctor's consultations. This involves an AI notetaker being used during doctor's consultations to summarise the conversation between the GP and patient. …
Phase: NA • Sponsor: University of Auckland, New Zealand • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Phone calls with a pharmacist may help smokers kick the habit
Symptom relief OngoingThe goal of this study is to assess the effectiveness of a remote pharmacist intervention to help smokers quit. The main questions it aims to answer are: * Will smokers being screened for lung cancer with low-radiation-level chest computed tomography (CT) be willing to particip…
Phase: NA • Sponsor: University of Iowa • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Child care workers get a mental health boost in new study
Symptom relief Recruiting nowThe goal of this 15-month cluster clinical trial is to compare a resilience and stress management program to a physical activity program for early childhood education (ECE) staff on change in well-being. It will also look to see if changes in well-being continue over time. The s…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
New study compares two root canal methods to reduce post-treatment pain
Symptom relief CompletedThis study aims to compare two commonly used root canal instrumentation systems, WaveOne (reciprocating system) and ProTaper (rotary system), in patients diagnosed with symptomatic irreversible pulpitis. Root canal treatment is performed to remove inflamed pulp tissue, disinfect …
Phase: NA • Sponsor: Armed Forces Institute of Dentistry, Pakistan • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Scientists probe hidden immune cells behind hepatitis b vaccine protection
Knowledge-focused Recruiting now296 million people worldwide are infected with the hepatitis B virus (HBV), despite the existence of an effective prophylactic vaccine. Current treatments (nucleoside analogues and pegylated interferon-α) do not prevent chronic hepatitis B (CHB) patients from developing liver fib…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New oral weight loss drug enters human testing
Disease control Recruiting nowThis is a Phase 1, single-center, randomized, placebo-controlled, ascending dose study. The study will evaluate the pharmacokinetics (PK), pharmacodynamic (PD), preliminary efficacy, safety and tolerability of BGM0504 following daily oral administrations in non-diabetic overweigh…
Phase: PHASE1 • Sponsor: BrightGene Bio-Medical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 18:49 UTC
-
Could your own tooth help a dental implant heal faster?
Disease control Recruiting nowThis randomized clinical study aims to evaluate the effect of autologous demineralized dentin graft (ADDG) with or without melatonin gel on the osseointegration of immediately placed dental implants in the maxillary premolar region. Sixteen patients requiring extraction and immed…
Phase: NA • Sponsor: Suez Canal University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
One-Leg workout may boost both legs in seniors
Knowledge-focused ENROLLING_BY_INVITATIONUnilateral resistance training has been shown to promote strength adaptations in the directly trained limb and also improve strength in the contralateral limb, a phenomenon known as cross-education (CE), with more pronounced effects observed in high-load training. However, high-l…
Phase: NA • Sponsor: Paulista University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC